| Old Articles: <Older 7751-7760 Newer> |
|---|
 |
The Motley Fool
June 7, 2005
Tom Taulli |
Scripps-Zilla By buying Shopzilla, E.W. Scripps becomes the latest traditional-media outfit to venture into the online world. Investors, steer clear for the time being.   |
The Motley Fool
June 7, 2005
Stephen D. Simpson |
Is Albertson's Fighting the Inevitable? Albertson's appears to be on the mend, but will it matter to investors? |
The Motley Fool
June 7, 2005
Shannon Zimmerman |
Secrets of Successful Fund Managers An oft-overlooked key point in the great stocks vs. mutual funds debate is that investing is never an either/or proposition. |
The Motley Fool
June 7, 2005
Nathan Parmelee |
Dividend Traps The allure of a large dividend isn't always what it's cracked up to be. Here is a look at companies with large dividends and the traps that await investors if they ignore how a company funds its dividend. |
The Motley Fool
June 7, 2005
Brian Gorman |
Covance Under Fire The contract research company could suffer at the hands of the animal-rights group PETA. The value of a company's public image is hard to quantify. For investors, this is definitely a case worth watching. |
BusinessWeek
June 13, 2005
Lauren Young |
Report Cards On Governance Morningstar and ISS both give grades on corporate governance, but their rating systems differ widely. |
The Motley Fool
June 6, 2005
Jeremy MacNealy |
Fashion Face-Off: Cool Rules The latest sales figures of Gap and Abercrombie & Fitch tell the story of what's hot and what's not. Where should you invest? |
The Motley Fool
June 6, 2005
W.D. Crotty |
Glacier's Troubled Waters Glacier Water has a novel concept, but so far, the dollars aren't exactly pouring in. The stock is overpriced until the company can show much higher revenues. |
The Motley Fool
June 6, 2005
Tim Beyers |
Say It Ain't So, Joe Things just don't look good for former Qwest CEO Joe Nacchio. Did Nacchio know Qwest's asset sales were being misclassified as he guided towards higher earnings? Investors, take note. |
The Motley Fool
June 6, 2005
Stephen D. Simpson |
"Bad News" for Teva? Yawn... Be ready to act when the market overreacts. For those investors who think that Teva Pharmaceutical will maintain its top-dog status in the generics world, this is just a blip on the scope and/or the opportunity to build a position. |
| <Older 7751-7760 Newer> Return to current articles. |
